Gavin Thurston

Active 1996–2026

104
Papers
29,063
Citations
78
h-index
102
i10-index

Citations

Citations per year for Gavin Thurston1990: 2 citations1992: 1 citations1997: 2 citations1998: 18 citations1999: 54 citations2000: 134 citations2001: 163 citations2002: 220 citations2003: 253 citations2004: 255 citations2005: 306 citations2006: 320 citations2007: 354 citations2008: 457 citations2009: 460 citations2010: 443 citations2011: 494 citations2012: 379 citations2013: 355 citations2014: 327 citations2015: 282 citations2016: 319 citations2017: 354 citations2018: 247 citations2019: 729 citations2020: 726 citations2021: 828 citations2022: 693 citations2023: 566 citations2024: 956 citations2025: 475 citations2026: 18 citations1991: no citations, so this year is not shown1993–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,798 citing papers, 30.4% of this breakdownChina: 1,215 citing papers, 9.7% of this breakdownGermany: 907 citing papers, 7.3% of this breakdownUnited Kingdom: 800 citing papers, 6.4% of this breakdownItaly: 494 citing papers, 4% of this breakdownJapan: 474 citing papers, 3.8% of this breakdownCanada: 418 citing papers, 3.3% of this breakdownFrance: 390 citing papers, 3.1% of this breakdownSwitzerland: 360 citing papers, 2.9% of this breakdownNetherlands: 342 citing papers, 2.7% of this breakdownAustralia: 293 citing papers, 2.3% of this breakdownBelgium: 291 citing papers, 2.3% of this breakdown
0%30.4%Other 21.8%

Fields

  • Medicine45.2%
  • Biochemistry, Genetics and Molecular Biology39.2%
  • Immunology and Microbiology5%
  • Neuroscience3.9%
  • Materials Science3.2%
  • Engineering2%
  • Other1.5%

Topics

  • Angiogenesis and VEGF in Cancer9.9%
  • Cancer, Hypoxia, and Metabolism3.4%
  • Lymphatic System and Diseases2.5%
  • Cancer Cells and Metastasis2.1%
  • Cancer Immunotherapy and Biomarkers1.9%
  • CAR-T cell therapy research1.8%
  • Other78.4%

Coauthors

All papers

Open in search
  1. Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lianjie Li, Christina Adler, Min Ni, Yi Wei, Wei Wang, Gurinder S. Atwal, Kunal Kundu, Kamil J. Cygan, Alexander M. Tsankov, Adeeb Rahman, Colles Price, Nicolás Fernández, Jiang He, Namita T. Gupta, Seunghee Kim‐Schulze, Sacha Gnjatic, Ephraim Kenigsberg, Raquel P. Deering, Myron Schwartz, Thomas U. Marron, Gavin Thurston, Alice O. Kamphorst, Miriam Mérad - Nature Medicine 2023 cited by 393

  2. Common and rare variant associations with clonal haematopoiesis phenotypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Raquel P. Deering, Charles Paulding, Alan R. Shuldiner, Gavin Thurston, Adolfo A. Ferrando, Will Salerno, Jeffrey G. Reid, John D. Overton, Jonathan Marchini, Hyun Min Kang, Aris Baras, Gonçalo R. Abecasis, Eric Jorgenson - Nature 2022 cited by 304

  3. Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas U. Marron, Ephraim Kenigsberg, Miriam Mérad - Cancer Cell 2021 cited by 350

  4. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. Hennequin, Hajra Jamal, Haley E. Brown, Antoinette Bonaccorso, Daniel M. Labow, Umut Sarpel, Talia D. Rosenbloom, Max W. Sung, Baijun Kou, Siyu Li, Vladimir Janković, Nicola James, Sara Hamon, Hung Kam Cheung, Jennifer S. Sims, Elizabeth Miller, Nina Bhardwaj, Gavin Thurston, Israel Lowy, Sacha Gnjatic, Bachir Taouli, Myron Schwartz, Miriam Mérad - ˜The œLancet. Gastroenterology & hepatology 2022 cited by 218

  5. Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

    Authors: , , , - Nature Reviews Molecular Cell Biology 2009 cited by 1,435

  6. Openings between Defective Endothelial Cells Explain Tumor Vessel Leakiness

    Authors: , , , , , , , - American Journal Of Pathology 2000 cited by 1,673

  7. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

    Authors: , , , , , , , , , , , - Nature Cell Biology 2010 cited by 976

  8. Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susana Puig, Frank Seebach, Gavin Thurston, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Timothy G. Bowler, Matthew G. Fury - The Lancet Oncology 2021 cited by 278

  9. Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

    Authors: , , , , , , , , , , , , , - Molecular Cancer Therapeutics 2017 cited by 164

  10. Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation

    Authors: , , , , , , , , , , , , , , - Nature Medicine 2006 cited by 914

  11. A framework for highly multiplexed dextramer mapping and prediction of T cell receptor sequences to antigen specificity

    Authors: , , , , , , , , , , , , , - Science Advances 2021 cited by 115

  12. Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashique Rafique, Tammy Huang, Frank J. Delfino, Aynur Hermann, Jessica R. Kirshner, Marc W. Retter, Robert Babb, Douglas MacDonald, Gang Chen, William C. Olson, Gavin Thurston, Samuel Davis, John Lin, Eric Smith - Scientific Reports 2021 cited by 110

  13. A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chia-Jen Siao, Drew Dudgeon, Tammy Huang, Terra Potocky, Joel Martin, Douglas MacDonald, A. Oyejide, Ashique Rafique, William Poueymirou, Jessica R. Kirshner, Eric Smith, William C. Olson, John Lin, Gavin Thurston, Matthew A. Sleeman, Andrew Murphy, George D. Yancopoulos - Science Translational Medicine 2020 cited by 153

  14. The Tie-2 ligand Angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies

    Authors: , , , , , , , , - Blood 2004 cited by 744

  15. The Complex Role of Angiopoietin-2 in the Angiopoietin-Tie Signaling Pathway

    Authors: , - Cold Spring Harbor Perspectives in Medicine 2012 cited by 262

  16. Angiopoietin-1 protects the adult vasculature against plasma leakage

    Authors: , , , , , , , , , - Nature Medicine 2000 cited by 1,291

  17. Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1

    Authors: , , , , , , , , , , , , , - Developmental Cell 2002 cited by 1,013

  18. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 776

  19. A novel, native-format bispecific antibody triggering T-cell killing of B-cells is robustly active in mouse tumor models and cynomolgus monkeys

    Authors: , , , , , , , , , , , , , , , , , - Scientific Reports 2015 cited by 165

  20. CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew Murphy, Eric Smith, Vladimir Janković, Matthew A. Sleeman, Dimitris Skokos - Science Translational Medicine 2022 cited by 52

  21. Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2016 cited by 240

  22. Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment

    Authors: , , , , , , , , , , , - Cancer Research 2018 cited by 220

  23. Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Teresa Schulenburg, Randi Foster, Pamela Krueger, Elena Garnova, Ashique Rafique, Robert Babb, Gang Chen, Nicole Stokes Oristian, Chia-Jen Siao, Christopher Daly, Cagan Gurer, Joel Martin, Lynn E. Macdonald, Douglas MacDonald, William Poueymirou, Eric Smith, Israel Lowy, Gavin Thurston, William C. Olson, John Lin, Matthew A. Sleeman, George D. Yancopoulos, Andrew Murphy, Dimitris Skokos - Science Translational Medicine 2020 cited by 93

  24. A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 cited by 141